Thalidomide and the immune system. 4. Down-regulation of the CD26 receptor, probably involved in the binding of HIV components to T cells in primates
- 30 December 1994
- journal article
- Published by Elsevier in Life Sciences
- Vol. 56 (6) , 407-420
- https://doi.org/10.1016/0024-3205(94)00906-6
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Thalidomide and the immune system 3. simultaneous up- and down-regulation of different integrin receptors on human white blood cellsLife Sciences, 1994
- CD26: a surface protease involved in T-cell activationImmunology Today, 1994
- Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation.The Journal of Experimental Medicine, 1993
- Thalidomide derivatives and the immune system. I. Changes in the pattern of integrin receptors and other surface markers on T lymphocyte subpopulations of marmoset bloodArchives of Toxicology, 1993
- HIV interactions with CD4: a continuum of conformations and consequencesImmunology Today, 1992
- Thalidomide and the immune system 2. Changes in receptors on blood cells of a healthy volunteerLife Sciences, 1992
- HIV-1 entry into quiescent primary lymphocytes: Molecular analysis reveals a labile, latent viral structureCell, 1990
- Cellular uptake of the tat protein from human immunodeficiency virusCell, 1988
- A Transcriptional Activator Protein Encoded by the x- lor Region of the Human T-Cell Leukemia VirusScience, 1985
- Involvement of Plasma Membrane Dipeptidyl Peptidase IV in Fibronectin-Mediated Adhesion of Cells on CollagenBiological Chemistry Hoppe-Seyler, 1985